BICYCLE THERAPEUTICS PLC - Common Stock (BCYC)
CUSIP: 088786108
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 49,984,905
- Total 13F shares
- 7,328,435
- Share change
- -221,505
- Total reported value
- $131,544,000
- Price per share
- $17.95
- Number of holders
- 27
- Value change
- -$3,975,466
- Number of buys
- 16
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 088786108?
CUSIP 088786108 identifies BCYC - BICYCLE THERAPEUTICS PLC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 088786108:
Top shareholders of BCYC - BICYCLE THERAPEUTICS PLC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD |
13F
|
Company |
3.9%
|
1,957,961
|
$37,299,000 | — | 30 Sep 2020 | |
| SV Health Investors, LLC |
13F
|
Company |
3.8%
|
1,915,274
|
$36,486,000 | — | 30 Sep 2020 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
2.7%
|
1,363,151
|
$25,968,000 | — | 30 Sep 2020 | |
| Atlas Venture Advisors, Inc. |
13F
|
Company |
2.6%
|
1,306,965
|
$24,898,000 | — | 30 Sep 2020 | |
| SAMLYN CAPITAL, LLC |
13F
|
Company |
0.84%
|
418,482
|
$7,972,000 | — | 30 Sep 2020 | |
| FMR LLC |
13F
|
Company |
0.42%
|
211,444
|
$4,028,000 | — | 30 Sep 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.3%
|
151,730
|
$2,890,000 | — | 30 Sep 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.12%
|
59,500
|
$1,133,000 | — | 30 Sep 2020 | |
| Laurion Capital Management LP |
13F
|
Company |
0.12%
|
57,892
|
$1,103,000 | — | 30 Sep 2020 | |
| Verition Fund Management LLC |
13F
|
Company |
0.06%
|
31,031
|
$591,000 | — | 30 Sep 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.05%
|
26,100
|
$497,000 | — | 30 Sep 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
20,345
|
$388,000 | — | 30 Sep 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
13,481
|
$257,000 | — | 30 Sep 2020 | |
| Pentwater Capital Management LP |
13F
|
Company |
0.02%
|
12,000
|
$229,000 | — | 30 Sep 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
3,989
|
$76,000 | — | 30 Sep 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
495
|
$9,000 | — | 30 Sep 2020 | |
| Houlihan Financial Resource Group, Ltd. |
13F
|
Company |
0%
|
223
|
$4,000 | — | 30 Sep 2020 | |
| Advisory Services Network, LLC |
13F
|
Company |
0%
|
100
|
$2,000 | — | 30 Sep 2020 |
Institutional Holders of BICYCLE THERAPEUTICS PLC - Common Stock (BCYC) as of Q4 2020
As of 31 Dec 2020,
BICYCLE THERAPEUTICS PLC - Common Stock (BCYC) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,328,435 shares.
The largest 10 holders included
TYBOURNE CAPITAL MANAGEMENT (HK) LTD, SV Health Investors, LLC, Point72 Asset Management, L.P., Atlas Venture Advisors, Inc., SAMLYN CAPITAL, LLC, FMR LLC, VICTORY CAPITAL MANAGEMENT INC, AXA S.A., RENAISSANCE TECHNOLOGIES LLC, and MOODY ALDRICH PARTNERS LLC.
This page lists
27
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
18
Q4 2020 holders
27
Holder diff
9
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.